|
|
 |
Search published articles |
 |
|
Showing 4 results for Entezari
Saghi Nooraei, Maliheh Entezari, Kiavash Hushmandi, Mehdi Raei, Volume 2, Issue 1 (Spring 2020)
Abstract
Viewpoint
Mehdi Pooladi, Maliheh Entezari, Mehrdad Hashemi, Alireza Bahonar, Kiavash Hushmandi, Mehdi Raei, Volume 2, Issue 1 (Spring 2020)
Abstract
The World Health Organization announced a state of emergency to deal with the new coronavirus on January 30, 2020. The COVID-19 pandemic started in Wuhan, China in December 2019, and due to the high contagiousness and rapid spread of the virus, it quickly involved the whole world in multiple problems. Efficient management has minimized the damage in some countries. In this review, we investigate the management practices of different countries. Rapid action, utilization of experience, forecasting and equipping of required infrastructure and use of all capabilities seem to be effective factors in controlling the new coronavirus pandemic in some countries.
Maryam Saeidi, Mahshad Kalantari, Ehsan Dordizadeh Basirabad, Maliheh Entezari, Volume 2, Issue 1 (Spring 2020)
Abstract
The new coronavirus, known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causes an infectious disease called coronavirus disease 19 (COVID-19). This disease is highly contagious, and it damages organs due to the high affinity of Spike protein for the human angiotensin-converting enzyme 2 (ACE2) cell receptor, which is highly expresses in organs such as the lungs, heart, liver, kidneys, brain, and bladder. These organs seems a probable host for the virus although the main target tissue of the virus is the lungs. In general, the virus enters the host cell by Spike protein, which it is a good candidate for the vaccine design. Inhibition or blockade of ACE2 receptors using antibodies that neutralize this receptor can be a hope to prevent the virus from invading the cell and causing damage.
Mehdi Pooladi, Maliheh Entezari, Ghazal Soleymani, Farnaz Ghaemi, Mehdi Raei, Mahshad Kalantari, Volume 3, Issue 4 (COVID-19 Supplement 2021)
Abstract
In late 2019, people around the world became involved with the outbreak of the emerging COVID-19 and its subsequent pandemic. For this reason, researchers in various fields are looking to solve problems related to crisis control and management. The strong transmission power of the SARS-CoV-2 has led experts to use artificial intelligence to combat the pandemic. Artificial intelligence refers to software that, in addition to analyzing data, can have decision-making power, in fact, it is an imitation of expert human intelligence. This study investigates the use of artificial intelligence during the COVID-19 pandemic. Advantages of using artificial intelligence in COVID-19 are presented in the areas of rapid detection and treatment, assistance with rapid diagnosis, monitoring of treatment stages, epidemiology and tracking of infected areas, pandemic status prediction, drug system management, reducing the workload of medical personnel, predicting and monitoring of COVID-19 outbreaks, follow-up of patients, vaccine planning and design. Also, high potential for the application of artificial intelligence in clinical and research laboratories has been estimated. Another potential use of artificial intelligence is to predict mutations that may occur in coronaviruses in the future and cause new symptoms and complications of the disease.
|
|